19.11.2017 von Reflux Medical
Background: During the past 40 years, esophageal/gastric cardia adenocarcinoma (EA/ GCA) incidence increased in Westernized countries, but survival remained low. A parallel increase in sugar intake, which may facilitate carcinogenesis by promoting hyperglycaemia, led us to examine sugar/carbohydrate intake in association with EA/GCA incidence and survival. Methods: We pooled 500 EA cases, 529 GCA cases and 2027 controls from two US population-based case-control studies with cases followed for vital status. Dietary intake, assessed by study-specific food frequency questionnaires, was harmonized and pooled to estimate 12 measures of sugar/carbohydrate intake. Multivariable-adjusted odds ratios (ORs) and hazard ratios [95% confidence intervals (CIs)] were calculated using multinomial logistic regression and Cox proportional hazards regression, respectively. Results: EA incidence was increased by 51–58% in association with sucrose
(ORQ5vs.Q1¼1.51, 95% CI¼1.01–2.27), sweetened desserts/beverages (ORQ5vs.Q1¼1.55, 95% CI¼1.06–2.27) and the dietary glycaemic index (ORQ5vs.Q1¼1.58, 95% CI¼1.13–2.21). Bodymass index (BMI) and gastro-esophageal Reflux disease (GERD) modified these associations (Pmultiplicative-interaction"0.05). For associations with sucrose and sweeteneddesserts/beverages, respectively, the OR was elevated for BMI<25 (ORQ4–5vs.Q1–3¼1.79, 95% CI¼1.26–2.56 and ORQ4–5vs.Q1–3¼1.45, 95% CI¼1.03–2.06), but not BMI#25 (ORQ4–5vs.Q1–3¼1.05, 95% CI¼0.76–1.44 and ORQ4–5vs.Q1–3¼0.85, 95% CI¼0.62–1.16). The EA-glycaemic index association was elevated for BMI#25 (ORQ4–5vs.Q1–3¼1.38, 95% CI¼1.03–1.85), but not BMI<25 (ORQ4–5vs.Q1–3¼0.88, 95% CI¼0.62–1.24). The sucrose-EA
association OR for GERD<weekly was 1.58 (95% CI¼1.16–2.14), but for GERD#weekly was 1.01 (95% CI¼0.70–1.47). Sugar/carbohydrate measures were not associated with GCA incidence or EA/GCA survival.
Conclusions: If confirmed, limiting intake of sucrose (e.g. table sugar), sweetened desserts/
beverages, and foods that contribute to a high glycaemic index, may be plausible
EA risk reduction strategies.